U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2003
181
Name Type Language
ANTI-CD11A
Preferred Name English
EFALIZUMAB
EMA EPAR   HSDB   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
EFALIZUMAB [HSDB]
Common Name English
HU1124
Code English
HU-1124
Code English
EFALIZUMAB [USAN]
Common Name English
EFALIZUMAB [MI]
Common Name English
Efalizumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD11A (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HU1124 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HU1124 LIGHT CHAIN, DIMER
Common Name English
EFALIZUMAB [VANDF]
Common Name English
EFALIZUMAB [EMA EPAR]
Common Name English
efalizumab [INN]
Common Name English
EFALIZUMAB [MART.]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD11A (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HU1124 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HU1124 LIGHT CHAIN, DIMER
Systematic Name English
Classification Tree Code System Code
WHO-ATC L04AA21
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
NDF-RT N0000175856
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
LIVERTOX NBK548791
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
EMA ASSESSMENT REPORTS RAPTIVA (WITHDRAWN: PSORIASIS)
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
NDF-RT N0000175856
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
NDF-RT N0000011174
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
NDF-RT N0000011174
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
NDF-RT N0000011174
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
NDF-RT N0000175856
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
WHO-VATC QL04AA21
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
NDF-RT N0000175858
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
Code System Code Type Description
RXCUI
356988
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY RxNorm
SMS_ID
100000089542
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
CAS
214745-43-4
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
INN
8122
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
NCI_THESAURUS
C68831
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
DRUG CENTRAL
4959
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
HSDB
7847
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
EVMPD
SUB20027
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
MERCK INDEX
m4837
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY Merck Index
IUPHAR
6593
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
WIKIPEDIA
EFALIZUMAB
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
USAN
LL-74
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
FDA UNII
XX2MN88N5D
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201575
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
DRUG BANK
DB00095
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
MESH
C472181
Created by admin on Mon Mar 31 20:47:24 GMT 2025 , Edited by admin on Mon Mar 31 20:47:24 GMT 2025
PRIMARY
ACTIVE MOIETY
EFALIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966